clusterProfiler 4.0: A universal enrichment tool for interpreting omics data
Safety Profile Across all six human trials and the extensive preclinical work, the safety picture is quite clean: No serious adverse events attributed to the compound No effect on IGF-1 No impairment of glucose tolerance or insulin sensitivity No genotoxic activity Most common side effects: mild injection site irritation, occasional headache or fatigue all transient This is genuinely one of the better-characterized peptides from a safety standpoint, largely because it actually went through a formal development process with proper clinical oversight
Last reviewed March 31, 2024 by Todd Gersten, MD, Hematology/Oncology, Florida Cancer Specialists & Research Institute, Wellington, FL
The product interface also includes repeated trust and action text that appears around vendor selection, coupon copying, email delivery of discount codes, product image galleries, certificate-of-analysis references, related guide cards, and footer links